Literature DB >> 11959632

Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart.

Baiqiu Wang1, Jianming Hao, Stephen C Jones, May-Sann Yee, Julie C Roth, Ian M C Dixon.   

Abstract

We examined the role of the transforming growth factor (TGF)-beta(1) signaling inhibitor Smad 7 in cardiac fibrosis. TGF-beta(1) (10 ng/ml) was found to increase cytosolic Smad 7 expression in primary adult rat fibroblasts and induce rapid nuclear export of exogenous Smad 7 in COS-7 cells. Furthermore, overexpression of Smad 7 in primary adult fibroblasts was associated with suppressed collagen type I and III expression. We detected Smad 7, phosphorylated Smad 2, TGF-beta type I receptor (TbetaRI), and TGF-beta(1) proteins in postmyocardial infarct (MI) rat hearts. In 2 and 4 wk post-MI hearts, Smad 7 and TbetaRI expression were decreased in scar tissue, whereas TGF-beta(1) expression was increased in scar and viable tissue. In the 8 wk post-MI heart, Smad 7 expression was decreased in both scar tissue and myocardium remote to the infarct scar. Finally, we confirmed that these changes are paralleled by decreased expression of cytosolic phosphorylated receptor-regulated Smad 2 in 4-wk viable myocardium and in 2- and 4-wk infarct scar tissues. Taken together, our data imply that decreased inhibitory Smad 7 signal in cardiac fibroblasts may play a role in the pathogenesis of cardiac fibrosis in the post-MI heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959632     DOI: 10.1152/ajpheart.00266.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  The role of the ubiquitin-proteasome system in kidney diseases.

Authors:  Hirotaka Fukasawa
Journal:  Clin Exp Nephrol       Date:  2012-06-09       Impact factor: 2.801

Review 3.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

Review 4.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

5.  Evidence for an Important Role of Smad-7 in Intervertebral Disc Degeneration.

Authors:  Bo Li; Yi-Jun Su; Xin-Feng Zheng; Yue-Hua Yang; Sheng-Dan Jiang; Lei-Sheng Jiang
Journal:  J Interferon Cytokine Res       Date:  2015-03-26       Impact factor: 2.607

6.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

7.  Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.

Authors:  Manar Hamed Arafa; Nanies Sameeh Mohammad; Hebatallah Husseini Atteia; Hesham Radwan Abd-Elaziz
Journal:  J Physiol Biochem       Date:  2014-06-18       Impact factor: 4.158

8.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Authors:  Dolkun Rahmutula; Gregory M Marcus; Emily E Wilson; Chun-Hua Ding; Yuanyuan Xiao; Agnes C Paquet; Rebecca Barbeau; Andrea J Barczak; David J Erle; Jeffrey E Olgin
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

Review 9.  Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.

Authors:  Hae Jin Kee; Hyun Kook
Journal:  J Biomed Biotechnol       Date:  2010-11-29

Review 10.  Progression and regression in renal vascular and glomerular fibrosis.

Authors:  Christos Chatziantoniou; Jean-Jacques Boffa; Pierre-Louis Tharaux; Martin Flamant; Pierre Ronco; Jean-Claude Dussaule
Journal:  Int J Exp Pathol       Date:  2004-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.